https://charts.traderzeitung.de/phases/US92511W2070 string(1409) "{"isin":"US92511W2070","name":"Verrica Pharmaceuticals Inc","stock_id_xnas":132475925,"stock_id_xnys":132475926,"generated_at":"2026-09-24 01:34:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.51,"close_at":"2026-09-21 18:24:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.72,"close_at":"2026-09-22 21:58:00","complete":true,"perf_pct":4.6563},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.64,"close_at":"2026-09-23 21:31:00","complete":true,"perf_pct":-1.6949},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Verrica Pharmaceuticals Aktie News & Nachrichten

[WKN: A41A98 | Symbol: VRCA]

Realtimekurs

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Verrica Pharmaceuticals gefunden werden.

Verrica Pharmaceuticals Nachrichtenticker öffnen

MT Newswires 28.08.2026 12:28 Uhr

Lake Street stuft Verrica Pharmaceuticals mit Buy und einem Kursziel von 9 USD ein

06:27 AM EDT, 08/28/2026 (MT Newswires) -- Verrica Pharmaceuticals (VRCA) has an average rating of buy and mean price target of $13.83, according to a

MT Newswires 21.07.2026 14:43 Uhr

Verrica Pharmaceuticals Signs Distribution Deal With Medomie for Molluscum Treatment

08:42 AM EDT, 07/21/2026 (MT Newswires) -- Verrica Pharmaceuticals (VRCA) said Tuesday that it has granted Medomie Pharma rights to seek regulatory ap

MT Newswires 22.06.2026 14:52 Uhr

Verrica Pharmaceuticals verabreicht erstem US-Patienten Dosis in Phase-3-Studie zur Bewertung von Ycanth zur Behandlung von gewöhnlichen Warzen

08:50 AM EDT, 06/22/2026 (MT Newswires) -- Verrica Pharmaceuticals (VRCA) teilte am Montag mit, dass der erste US-Patient eine Dosis in der zweiten kl